Literature DB >> 3947168

The role of venography and surgery in the management of patients with superior vena cava obstruction.

W Stanford, D B Doty.   

Abstract

Venacavography proved to be an excellent guide for the design of patient management programs. Type 1 patients with incomplete obstruction of the superior vena cava (SVC) are best managed by irradiation and chemotherapy regimens and usually do not require operation to bypass the SVC. Types II and IV patients are treated by operation when symptoms of airway obstruction or cerebral venous hypertension are present. Type III patients should be considered for SVC bypass as an initial therapeutic intervention. This group is more likely to have cerebral or airway symptoms and would benefit most from the bypass operation. In terms of operative considerations, type III patients are ideal for operation because the left brachiocephalic vein is usually available for bypass. Type IV patients may also be considered, but operation is more difficult and may require venous thrombectomy or extension of the bypass graft above the thoracic inlet to obtain head and neck decompression.

Entities:  

Mesh:

Year:  1986        PMID: 3947168     DOI: 10.1016/s0003-4975(10)62659-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Endovascular Therapy for Central Venous Thrombosis.

Authors:  Adam M Gwozdz; Justinas Silickas; Alberto Smith; Prakash Saha; Stephen A Black
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

Review 2.  Stenting of superior vena caval obstruction.

Authors:  J E Jackson; D M Brooks
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

3.  New approach to superior vena caval obstruction.

Authors:  I Robinson; J Jackson
Journal:  BMJ       Date:  1994-06-25

4.  Comparison of Covered Versus Uncovered Stents for Benign Superior Vena Cava (SVC) Obstruction.

Authors:  Mustafa M Haddad; Benjamin Simmons; Ian R McPhail; Manju Kalra; Melissa J Neisen; Matthew P Johnson; Andrew H Stockland; James C Andrews; Sanjay Misra; Haraldur Bjarnason
Journal:  Cardiovasc Intervent Radiol       Date:  2018-02-28       Impact factor: 2.740

5.  Stenting and superior vena caval syndrome.

Authors:  P Wilkinson; J MacMahon; L Johnston
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

6.  Expandable Wallstent for the treatment of obstruction of the superior vena cava.

Authors:  A F Watkinson; D M Hansell
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

Review 7.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02

8.  Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.

Authors:  Yu-Il Kim; Kyu-Sik Kim; Young-Chun Ko; Chang-Min Park; Sung-Chul Lim; Young-Chul Kim; Kyung-Ok Park; Woong Yoon; Yoon-Hyun Kim; Jae-Kyu Kim; Sung-Ja Ahn
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

9.  Effectiveness of sharp recanalization of superior vena cava-right atrium junction occlusion.

Authors:  Xiao-Wen Wu; Xu-Ya Zhao; Xing Li; Jun-Xiang Li; Zong-Yang Liu; Zhi Huang; Ling Zhang; Chong-Yang Sima; Yu Huang; Lei Chen; Shi Zhou
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.